Medidata Solutions (a Dassault Systèmes company)

350 Hudson Street, New York, NY, United States  All United States companies → Founded 1999
Biotech / Drug Discovery Healthcare Analytics / BI
Family Medicine Internal Medicine Oncology
Acquired (formerly Public) — $41.5M

About Medidata Solutions (a Dassault Systèmes company)

Medidata Solutions, a Dassault Systèmes company, is a leading technology provider for clinical trials, driving the digital transformation of life sciences. The company offers a unified, cloud-based platform that addresses the entire clinical research process, from study design to data management and analysis. This platform helps pharmaceutical, biotech, medical device, and diagnostics companies, as well as academic researchers, accelerate value, minimize risk, and optimize outcomes in their clinical development.

For physicians, Medidata’s platform provides tools to streamline clinical trial workflows and improve data quality. Key products include Medidata Rave EDC (Electronic Data Capture) for managing clinical trial data and Medidata Rave Clinical Cloud for patient-related data. The company emphasizes a patient-centric approach, offering solutions like Medidata Patient Cloud apps and the myMedidata patient portal, and is actively involved in decentralized clinical trials (DCT) that allow for remote patient participation. Medidata also leverages AI-powered insights to enhance various aspects of clinical research, including automated study builds and the creation of synthetic control arms, which can help design more precise, predictive, and inclusive trials.

Medidata’s solutions are designed to help generate evidence and insights, manage clinical data and operations, and support decentralized clinical trials, ultimately transforming the clinical trial experience for all stakeholders, including patients, sponsors, CROs, and research sites. The company’s extensive experience, with over 38,000 trials and 12 million patients supported, combined with its analytics-powered insights and one of the largest clinical trial data sets in the industry, positions it as a crucial partner in bringing innovative therapies to market faster.

Focus Areas

Clinical trial software SaaS for clinical trials electronic data capture (EDC) clinical data management patient cloud AI in clinical development real-world data decentralized clinical trials clinical trial analytics

Business Intelligence

Key InvestorsInsight Venture Partners, Milestone Venture Partners, Silicon Alley Venture Partners, Activate Venture Partners, TFS HealthScience
PartnershipsIXICO plc, Stemline Therapeutics, Inc., MENARINI Group, CRIO, Inc., National Cancer Institute, CTI Clinical Trial and Consulting
AcquisitionsFast Track Systems (2008), Clinical Force (2011), Patient Profiles (2014), Intelemage (2016), Chita (2017), Mytrus (2017), SHYFT Analytics (2018), MC10 (2020), Acquired by Dassault Systèmes (2019)
TechnologyCloud-based, unified platform (Medidata Rave Clinical Cloud) with AI-powered insights, offering Patient Experience, Data Experience, and Study Experience solutions.

What Physicians Need to Know

Clinical Trial Optimization
Medidata specializes in using AI and advanced analytics to optimize every stage of clinical trials, from design and planning to execution, management, and reporting. This includes intelligent protocol optimization, study feasibility analysis, and automated data management workflows.
Data Management & Quality
Their solutions focus on unifying disparate data sources, enhancing data quality through AI-driven anomaly detection, automating medical coding, and streamlining data review cycles. Products like Clinical Data Studio and Health Record Connect are key in this area.
Patient Engagement & Experience
Medidata offers an end-to-end patient portal (myMedidata) that provides tools for eConsent, eCOA, sensor data collection, and live video visits, aiming to reduce patient burden and improve engagement in trials, including decentralized and hybrid models.
Medical Imaging Management
They provide AI-powered solutions for medical imaging management, particularly in oncology and other image-dependent studies. This includes faster redaction of protected health information and highly accurate anatomy verification.
Real-World Data & Evidence
Medidata integrates real-world data insights and offers solutions like Synthetic Control Armu00ae, which leverages historical clinical trial data to create external control groups, potentially reducing the need for placebos in certain trials.
Therapeutic Area Focus
Medidata has a strategic focus on specialized therapeutic areas like oncology and central nervous system (CNS) trials, developing targeted digital tools, biomarkers, and trial management systems for these fields.
Physician Tip

For physicians, Medidata's AI tools can significantly streamline participation in clinical trials by automating administrative tasks, improving data accuracy, and providing real-time insights into study progress. The patient portal (myMedidata) facilitates patient engagement and remote monitoring, reducing the logistical burden on both patients and sites. The AI-powered imaging solutions offer faster and more precise analysis, especially critical in oncology. Furthermore, Medidata's solutions can help physicians understand prescription patterns and optimize outreach strategies for new treatments.

Medidata's platform is designed for end-to-end clinical trial management, integrating data from various sources including EHRs, labs, and patient-reported outcomes. Key integrations include Health Record Connect for healthcare data interoperability and Companion for eSource/EHR-to-EDC data transfer. The platform aims to unify disparate data sources to provide a comprehensive view of trial data.

Products by Medidata Solutions (a Dassault Systèmes company)

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Medidata Solutions, a Dassault Systu00e8mes company, is a prominent provider of cloud-based solutions for clinical trials in life sciences. Their platform supports the entire clinical development process, from planning and management to data analysis. The company generally receives positive feedback for its products, particularly Medidata Rave, which is widely used in clinical data management. Employer reviews are mixed, with many praising the company culture and benefits, while others express concerns about management and career advancement.

Overall: Mixed

Strengths

  • Medidata Rave is user-friendly and easy to navigate and learn.
  • Strong integration capabilities with other clinical trial tools.
  • Good customer service and support for products.
  • Offers comprehensive training videos for its CTMS.
  • Positive company culture, good work-life balance, and benefits like unlimited PTO (for some roles).
  • Innovation-focused environment with opportunities for growth.

Limitations

  • The user interface of some products, like Medidata CTMS and older versions of Rave, can appear archaic and less intuitive.
  • Frequent logouts due to inactivity are a common complaint for Medidata Rave.
  • Some users find the help center response time to be slow.
  • Cost can be high for smaller companies, with no free version or trial for Medidata CTMS.
  • Concerns about middle management, lack of raises/promotions after a few years, and uncommunicated layoffs have been raised by employees.
  • Some employees feel overworked and that the company does not reward dedication.

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Indeed.com, Gartner Peer Insights, Great Place To Work, SimplyHired

Last updated: 2026-09-10

Videos

News, demos, and interviews about Medidata Solutions (a Dassault Systèmes company).

Loading videos...

Videos load interactively. If none appear, search YouTube for Medidata Solutions (a Dassault Systèmes company) →

View all on YouTube

Press & Coverage

Medidata Solutions
Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios
Medidata, a Dassault Systu00e8mes brand, launched Medidata Plus, a clinical artificial intelligence layer designed to scale AI capabilities across the Medidata Platform and accelerate the delivery of life-saving therapies. This new offering aims to unify AI strategy in life sciences, moving away from disjointed point solutions.
2026-07
Medidata Solutions
Medidata Expands Executive Leadership Team to Scale Operations and Accelerate Growth for Customers
Medidata announced key appointments to its executive leadership team, including Lisa Moneymaker as Chief Operating Officer and Chief Strategy Officer, to reinforce its commitment to customer-centric innovation and operational excellence. This expansion aims to streamline strategy and operations, and accelerate growth for customers globally.
2026-08
Medidata Solutions
Medidata's Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials
Medidata unveiled its enhanced, AI-powered imaging solution at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting, designed to deliver unprecedented accuracy and speed for clinical trials, particularly in oncology. The solution integrates established AI with direct feedback from clinical study teams to overcome traditional imaging bottlenecks.
2026-05
Medidata Solutions
Medidata's Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines
Medidata released its second annual report, 'The State of AI in Clinical Trialsu00a9', revealing a shift from experimental AI pilots to enterprise-wide adoption, with 72.9% of early adopters experiencing reduced clinical trial timelines. The report highlights the significant advantage for organizations with a longer track record of operationalizing AI.
2026-05
Medidata Solutions
Medidata Delivers a Decade of AI Leadership to 500+ Clinical Studies and Growing
Medidata announced that its AI technology has been scaled across the Medidata Platform, benefiting over 500 clinical studies in the last decade, including more than 120 AI-supported studies starting in 2025. This demonstrates the company's continued acceleration of clinical trial success through enhanced AI-powered capabilities.
2026-02
JAMA Network Open
Linkage of Clinical Trial Data to Routinely Collected Data Sources: A Scoping Review
This peer-reviewed article, co-authored by Medidata Solutions, reviews clinical trials linked to routinely collected data, identifying use cases and designs of these linkage studies. The research highlights how linking routinely collected data with clinical trial data can provide deeper insights into treatment benefits, risks, and costs.
2025-04
Startup Fundraising
How Much Has Medidata Solutions Raised? $13M in Total - Startup Fundraising
Medidata Solutions has raised a total of $13 million in disclosed funding, with the latest update approximately one month ago. The company's funding history includes a round in January 2009.
2026-07
The Venture Codex
Medidata Solutions Investments & Fund Profile | The Venture Codex
Medidata Solutions has made strategic investments, including in Circuit Clinical's $27M Series C funding, to expand its decentralized clinical trial network. This investment aims to standardize Circuit Clinical sites on Medidata's RAVE and myMedidata technology solutions.
unknown

Frequently Asked Questions

Medidata offers a range of AI-powered solutions primarily focused on optimizing clinical trials. Key products include Medidata AI, which is purpose-built for clinical trials and trained on extensive validated data to accelerate breakthroughs. Specific AI-driven tools are embedded across their Patient, Data, and Study Experiences, such as AI Study Build for faster trial initiation, AI-powered imaging solutions for enhanced precision and speed in oncology trials, and Protocol Optimization that uses machine learning to suggest study design changes and forecast their impact.
Medidata prioritizes data privacy and security, adhering to stringent global privacy regulations and employing a 'privacy by design' approach. They utilize Advanced Encryption Standard 256 (AES-256) for data at rest and Transport Layer Security (TLS 1.2) for data in transit. Medidata's information security program is ISO 27001 certified and they were the first life sciences organization to receive an ISO 27701 Certification and the only one to receive a SOC2+ Certification, demonstrating their commitment to protecting sensitive clinical trial data.
While specific pricing details are not publicly available in the search results, Medidata encourages prospective clients to contact their specialists directly to explore pricing and next steps. They offer solutions for various needs, from individual studies to enterprise-wide deployments across multiple phases and therapeutic areas.
Medidata provides comprehensive support and implementation services, aiming to unify stakeholder experiences within their platform. They offer resources such as fact sheets, reports, webinars, and educational materials. Their approach includes user research, usability testing, global information architecture, and a design system to ensure a smooth onboarding process and enriched experience for customers.
Medidata actively engages in strategic partnerships to expand its AI capabilities in life sciences. They have an expanded partnership with Sanofi, leveraging Medidata Patient, Data, and Study Experiences for optimizing clinical trials and accelerating drug development. Additionally, Medidata has partnered with Anthropic to integrate Medidata's AI-powered insights with Claude's advanced reasoning for clinical intelligence, and with Worldwide Clinical Trials to embed Medidata AI across the full trial lifecycle.
Medidata Solutions has been a subsidiary of Dassault Systu00e8mes since 2019, acquired for approximately $5.8 billion. Dassault Systu00e8mes is a global leader in 3D design software, 3D digital mock-up, and product lifecycle management solutions, providing a strong and stable parent company for Medidata. Medidata itself has over 25 years of innovation, supporting over 38,000 trials and 12 million patients, demonstrating a long-standing presence and reliability in the clinical trial technology space. Their information security program also boasts a 99.99% uptime.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.